Patent ID: 6743429
Filing Date: 2004-06-01
Classification: A61K,A61P,Y10S

Abstract:
A method of reducing a stimulus-induced airway response selected from the group consisting of airway constriction, bronchospasm, airway hyperreactivity, eosinophil accumulation in bronchial walls, an increase in airway resistance, or combinations thereof, said method comprising:administering by inhalation to a subject at risk of experiencing said stimulus-induced airway response a therapeutically effective amount of an agent selected from the group consisting of: (a) human calcitonin gene-related peptide (human CGRP); (b) rat CGRP; (c) the diacetoamidomethyl cysteine form of (a); and (d) the diacetoamidomethyl cysteine form of (b); wherein said agent is administered prior to said airway response and wherein said method results in no or substantially no haemodynamic side effects.